or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    AGEN F Agenus Inc. 3.93
    INDP F Indaptus Therapeutics, Inc. 2.17
    MRNA C Moderna, Inc. 1.90
    RENB F Renovaro Biosciences Inc. -1.03
    EVAX D Evaxion Biotech A/S -4.03
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    GERM B ETFMG Treatments Testing and Advancements ETF 8.33
    BBH B Market Vectors Biotech ETF 5.98
    GNOM D Global X Genomics & Biotechnology ETF 5.54
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.51
    IBBQ B Invesco Nasdaq Biotechnology ETF 5.08
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare BBH to IBBQ Compare BBH to IDNA Compare GERM to BBH

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        May 21 MRNA Moderna trades in the green for seventh straight session
        May 21 MRNA Sanofi (SNY) Signs Deal for AI-Powered Drug Development
        May 21 MRNA ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
        May 21 MRNA Selling US$3.3m Of Moderna Stock Rewarded Insiders
        May 20 MRNA Aggressive Strides Forward For Moderna's Cancer Vaccine
        May 20 MRNA Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
        May 20 MRNA Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
        May 20 MRNA Pfizer wins cancer drug patent case against AstraZeneca
        May 17 MRNA Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
        May 17 MRNA European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
        May 17 MRNA Moderna vaccine patent upheld by European Patent Office: report
        May 17 MRNA Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 MRNA Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 MRNA The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
        May 17 MRNA Could Novavax Become the Next Moderna?
        May 16 MRNA Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 MRNA Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
        May 16 AGEN FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
        May 15 MRNA Moderna Q1: A Promising Pipeline Is Undervalued
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags